Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Breast Cancer Research and Treatment
|
July 25, 2023
Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence
Bartosz Dołęga-Kozierowski, Piotr Kasprzak, Michał Lis, et al.
Journal of Medicinal Chemistry
|
July 1, 2026
Engineering Cathepsin S Selective Chemical Probes and Antibody-Drug Conjugates through Substrate Profiling with Unnatural Amino Acids
Maria Łęcka, Oliwia Gorzeń, Natalia Ćwilichowska-Puślecka, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 27, 2025
Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer
Oliwia Gorzeń, Maria Łęcka, Natalia Ćwilichowska-Puślecka, et al.
International Journal of Antimicrobial Agents
|
March 15, 2023
LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring
Cindy Lau, Deborah Marriott, Jessica Bui, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Breast Cancer Research and Treatment
|
July 25, 2023
Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence
Bartosz Dołęga-Kozierowski, Piotr Kasprzak, Michał Lis, et al.
Journal of Medicinal Chemistry
|
July 1, 2026
Engineering Cathepsin S Selective Chemical Probes and Antibody-Drug Conjugates through Substrate Profiling with Unnatural Amino Acids
Maria Łęcka, Oliwia Gorzeń, Natalia Ćwilichowska-Puślecka, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 27, 2025
Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer
Oliwia Gorzeń, Maria Łęcka, Natalia Ćwilichowska-Puślecka, et al.
International Journal of Antimicrobial Agents
|
March 15, 2023
LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring
Cindy Lau, Deborah Marriott, Jessica Bui, et al.
Page
of 4